According to Shanghai Securities News, 85 companies landed on Hong Kong stock market in H1 2026, raising over HK$200 billion collectively. Among them, 11 were biotech firms under the 18A track and 13 specialized technology companies under the 18C track.
A+H dual listings emerged as a key trend, with 24 such offerings in H1 2026, surpassing the full-year 2025 total of 19. China International Capital Corporation (CICC) led underwriting activity, sponsoring 28 new listings and underwriting 36 Hong Kong IPOs.